Whalesbook
### The Market's Puzzling Reaction
Sagility's stock experienced a significant decline, shedding over 5% to an intraday low of ₹49.1 on the NSE, even as the healthcare business process management firm announced third-quarter results that surpassed analyst expectations. By early afternoon, the shares traded 3.5% lower at ₹49.92. This downturn occurred against a backdrop of a largely flat Nifty50 index, which registered a marginal dip of 0.07%. The company's market capitalization stood at ₹23,378 crore.
Q3 FY26 Performance Analysis
The October-December quarter of fiscal 2026 demonstrated robust financial growth for Sagility. Profit after tax (PAT) surged by 23% year-on-year to ₹322.9 crore, an improvement from ₹262.6 crore in the corresponding prior-year period. Revenue from operations saw a substantial 35.7% increase, reaching ₹1,971.2 crore compared to ₹1,453.1 crore a year ago. Earnings before interest, tax, depreciation, and amortization (EBITDA) also posted a healthy 24.2% rise, settling at ₹512.5 crore from ₹412.7 crore previously. Organic growth remained strong at 19.9% year-on-year, driven by deeper penetration within existing client relationships and contributions from newly acquired clients during FY26.
Navigating Growth and Margins
Sagility successfully onboarded three new clients during the December quarter, adding to the twelve acquired in the nine-month period ending December 31, 2025, bringing its total active client count to 81. Management reiterated a growth strategy centered on expanding into white-space opportunities, focusing on outcome-based managed services, and leveraging technology-led transformations, while selectively pursuing high-quality new client acquisitions. The company's strategic shift towards outcome-based engagements is designed to decouple revenue from transaction or headcount-based pricing models, thereby enhancing margin resilience. This strategic initiative led the company to raise its FY26 constant-currency revenue guidance to 22.5%, projecting 13.8% organic growth, while maintaining its adjusted EBITDA margin guidance at 25%.
Analyst Insights and Sector Context
Motilal Oswal Financial Services (MOFSL) acknowledged Sagility's strong Q3 performance, citing 29.1% year-on-year constant-currency growth fueled by client expansion and new business wins. The brokerage anticipates this momentum to continue into Q4FY26, supported by typical second-half seasonality. However, MOFSL observed that the conversion of recent strong deal wins into revenue could have been more efficient. They project approximately 7% sequential CC growth for Q4FY26 and around 22% for FY26, with an expectation of a strong exit setting the stage for FY27. On margins, MOFSL noted that the reported Q3 EBITDA margin of 25.9% fell within guidance. Despite the focus on outcome-based services, the brokerage forecasts only modest margin expansion in the near term, modeling EBITDA margins between 24% and 25% over FY26–28, citing ongoing pricing and cost pressures within the US health insurance sector. Competitors like Genpact (G) trade at a trailing P/E of approximately 26x, while WNS Global Services (WNS) is around 30x, and Firstsource Solutions hovers near 20x, placing Sagility's current trailing P/E of roughly 33x in context. The IT services sector globally faces headwinds from clients becoming more selective with spending, prioritizing clear ROI amidst potential economic slowdowns, though digital transformation and AI adoption continue to be growth drivers. Sagility's current trading price of approximately ₹49.85 is about 14% below its 52-week high of ₹57.89 reached on October 30, 2025. This contrasts with its Q2 FY26 earnings report, following which the stock saw a modest positive reaction. MOFSL reiterated its 'Buy' rating with a target price of ₹66, based on 22 times FY28E EPS, anticipating revenue, EBIT, and PAT CAGR of 21%, 30%, and 24% respectively, over FY25–28, driven by new client acquisitions, cross-selling, and acquisition synergies.